share_log

Needham Reiterates Hold on Sage Therapeutics

Benzinga ·  Apr 25 07:58

Needham analyst Ami Fadia reiterates Sage Therapeutics (NASDAQ:SAGE) with a Hold.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment